Abstract

We have read with interest the letter by O'Brien1 contributing to the debate on the respective role of home blood pressure (BP; HBP) monitoring (HBPM) and ambulatory BP (ABP) monitoring (ABPM) in the clinical management of hypertensive patients.2,3 We largely agree with O'Brien’s1 observations, although with a slightly different perspective. First, we agree that isolated HBP measurements are of limited clinical value. Indeed, only the average of repeated HBP readings carries diagnostic and prognostic information, which may be partly comparable to that provided by 24-hour ABPM,4 with most outcome studies being based …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call